Nov. 23, 2021 - Puma Biotechnology Announces U.S Patent Term Extension for NERLYNX® (neratinib) Read Nov. 20, 2021 - Puma Biotechnology Presents Data from the Neratinib Arm of the INSIGhT Trial at the 2021 SNO Annual Meeting Read Nov. 19, 2021 - Puma Biotechnology to Present Neratinib Data at the San Antonio Breast Cancer Symposium (SABCS) Read Nov. 4, 2021 - Puma Biotechnology Reports Third Quarter 2021 Financial Results Read Oct. 21, 2021 - Puma Biotechnology to Host Conference Call to Discuss Third Quarter Financial Results Read Sept. 21, 2021 - Puma Biotechnology to Present at the Cantor Virtual Global Healthcare Conference Read Sept. 7, 2021 - Puma Biotechnology to Present at the H.C. Wainwright 23rd Annual Global Investment Conference Read Aug. 5, 2021 - Puma Biotechnology Reports Second Quarter 2021 Financial Results Read July 26, 2021 - Puma Biotechnology Secures $125 Million Note Purchase by Athyrium Capital Read July 22, 2021 - Puma Biotechnology to Host Conference Call to Discuss Second Quarter Financial Results Read July 15, 2021 - NCCN Announces Selected Projects to Study Neratinib in Collaboration with Puma Biotechnology, Inc. Read July 1, 2021 - FDA Approves Dose Escalation Label Update for Puma Biotechnology’s NERLYNX® (neratinib) in HER2-Positive Early Stage and Metastatic Breast Cancer Read June 4, 2021 - Puma Biotechnology Presents Data Comparing Findings from the Phase II CONTROL Trial with the Neratinib Arm of the Phase III ExteNET Trial at the ASCO 2021 Annual Meeting Read June 4, 2021 - Puma Biotechnology Presents Data from the EGFR Exon 18-mutant NSCLC Cohort of the Phase II SUMMIT Trial at the 2021 ASCO Annual Meeting Read June 4, 2021 - Puma Biotechnology Presents Data from the Phase III ExteNET Trial in Early Stage HER2-Positive Breast Cancer Patients at the Virtual 2021 ASCO Annual Meeting Read May 19, 2021 - Puma Biotechnology Announces Publication of Abstracts on Neratinib for the 2021 ASCO Annual Meeting Read May 6, 2021 - Puma Biotechnology Reports First Quarter 2021 Financial Results Read April 22, 2021 - Puma Biotechnology to Host Conference Call to Discuss First Quarter Financial Results Read Upcoming Events Nov. 20, 2021 - Society for Neuro-Oncology Annual Meeting More Dec. 7-10, 2021 - San Antonio Breast Cancer Symposium More Past Events Oct. 21, 2021 - Puma Biotechnology 3Q-2021 Financial Results Conference Call More Sept. 28, 2021 - Cantor Virtual Global Healthcare Conference More Sept. 13-15, 2021 - H.C. Wainwright 23rd Annual Global Investment Conference More Aug. 5, 2021 - Puma Biotechnology 2Q-2021 Financial Results Conference Call More June 4-8, 2021 - ASCO 2021 Annual Meeting More May 6, 2021 - Puma Biotechnology 1Q-2021 Financial Results Conference Call More Mar. 11, 2021 - Barclays Global Healthcare Conference More Mar. 9, 2021 - H.C. Wainwright Global Life Sciences Conference More Mar. 2, 2021 - Cowen and Company 41st Annual Health Care Conference More Feb. 25, 2021 - Puma Biotechnology 4Q-2020 Financial Results Conference Call More Jan. 26-29, 2021 - IASLC 2021 World Conference on Lung Cancers More Jan. 21, 2021 - B. Riley Oncology Investor Conference More Jan. 15-17, 2021 - ASCO 2021 Gastrointestinal Cancers Symposium More Jan. 14, 2021 - 39th Annual J.P. Morgan Healthcare Conference More Jan. 11, 2021 - H.C. Wainwright VIRTUAL BioConnect Conference More Annual Report Archives Puma Biotechnology, Inc. 10880 Wilshire Blvd., Suite 2150 Los Angeles, CA 90024 424-248-6500 Main 424-248-6501 Fax Medical Inquiries: 1-844-MED-PUMA (1-844-633-7862), or medinfo@pumabiotechnology.com Business Development: info@pumabiotechnology.com Investor Relations: ir@pumabiotechnology.com Follow Us: © 2021 Puma Biotechnology, Inc. | Privacy Policy | Legal Notice | Site Map